Novo Nordisk

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novo Nordisk and other ETFs, options, and stocks.

About NVO

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. 

CEO
Maziar Mike Doustdar
CEOMaziar Mike Doustdar
Employees
76,302
Employees76,302
Headquarters
Bagsværd, Capital Region
HeadquartersBagsværd, Capital Region
Founded
1923
Founded1923
Employees
76,302
Employees76,302

NVO Key Statistics

Market cap
227.15B
Market cap227.15B
Price-Earnings ratio
14.90
Price-Earnings ratio14.90
Dividend yield
2.40%
Dividend yield2.40%
Average volume
18.54M
Average volume18.54M
High today
$51.26
High today$51.26
Low today
$50.50
Low today$50.50
Open price
$51.06
Open price$51.06
Volume
10.80M
Volume10.80M
52 Week high
$93.80
52 Week high$93.80
52 Week low
$43.08
52 Week low$43.08

NVO News

Barron's 10h
In the Year of the Weight-Loss Pill, Lilly Still Leads GLP-1s

Biotech and Pharma In the Year of the Weight-Loss Pill, Lilly Still Leads GLP-1s In this article NOVO.B LLY Novo Nordisk and Eli Lilly will introduce pill versi...

In the Year of the Weight-Loss Pill, Lilly Still Leads GLP-1s
Nasdaq 1d
Why Novo Nordisk Stock Dropped on Monday

Key Points No pharmaceutical stock investor likes it when one of their holdings slices drug prices. This one is reducing the costs of a top medicine in a huge...

Why Novo Nordisk Stock Dropped on Monday
TipRanks 3d
Midday Fly By: SoftBank buying DigitalBridge, Verisk drops AccuLynx deal

The major averages were broadly lower near noon to begin the final trading week of the year, as markets settle back into holiday mode after a strong rally that...

Analyst ratings

55%

of 33 ratings
Buy
54.5%
Hold
33.3%
Sell
12.1%

More NVO News

Benzinga 3d
What's Going On With Novo Nordisk Stock Monday? - Novo Nordisk - Benzinga

...

What's Going On With Novo Nordisk Stock Monday? - Novo Nordisk - Benzinga
Benzinga 3d
Novo Nordisk Halves Wegovy Prices In China Ahead Of Generic Threat

Novo Nordisk A/S (NYSE:NVO) has reportedly slashed list prices for its obesity drug Wegovy by about 50% in parts of China, signaling a defensive move ahead of r...

Nasdaq 3d
This Beaten-Down Stock Just Jumped By 8%. Time to Buy?

Key Points Pharmaceutical giant Novo Nordisk just earned approval for an oral version of Wegovy. This could help improve its position in the increasingly comp...

This Beaten-Down Stock Just Jumped By 8%. Time to Buy?
Nasdaq 3d
Novo Nordisk A/S Is a Trending Stock: Facts to Know Before Betting on It

Novo Nordisk (NVO) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could i...

Novo Nordisk A/S Is a Trending Stock: Facts to Know Before Betting on It
TipRanks 3d
Novo cuts listing prices for Wegovy in some Chinese provinces, Bloomberg says

Novo Nordisk (NVO) has cut the listing prices by half for its obesity drug Wegovy in some Chinese provinces as the company prepares for copycats to flood the ma...

TipRanks 5d
Novo Nordisk Soars as Wegovy Pill Changes the Game

Novo Nordisk ( (NVO) ) has risen by 8.94%. Read on to learn why. Claim 70% Off TipRanks This Holiday Season Unlock hedge fund-level data and powerful investing...

The Motley Fool 5d
Should You Invest in Ozempic Maker Novo Nordisk in 2026?

The pharmaceutical giant's stock has tumbled over the past year and a half, but it could be poised to storm back. Is there a more popular health trend right no...

Should You Invest in Ozempic Maker Novo Nordisk in 2026?
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.